copyright notices, etc
The Seaweed Gatherers, Paul Gaugin
|Box to be put at the bottom of every page:
copyright, disclaimer, other info about the site.
Resource Network of The Iodine Movement
Thyroid hormone and remyelination in adult central nervous system: a lesson from an inflammatory-demyelinating disease.
Calza L, Fernandez M, Giuliani A, D'Intino G, Pirondi S, Sivilia S, Paradisi M, Desordi N, Giardino L.
Brain Res Brain Res Rev. 2005 Apr;48(2):339-46. Epub 2005 Jan 26. Review.
Re-myelination in the adult CNS has been demonstrated in different experimental models of demyelinating diseases. However,
there is no clear evidence that re-myelination is effective in multiple sclerosis (MS), the most diffuse demyelinating disease.
Moreover, chronic disabilities in MS are believed to be due to remyelination failure and consequent neuron damage and
degeneration. Due to the presence of numerous oligodendrocyte precursors inside demyelination plaques, reasons for
remyelination failure are unknown. In this paper, we reviewed data from embryonic development and in vitro studies supporting
the primary role of thyroid hormone in oligodendrocyte maturation. We also reviewed personal data on the possibility of
promoting myelination in chronic experimental allergic encephalomyelitis (EAE), a widely used experimental model of MS, by
recruiting progenitors and channeling them into oligodendroglial lineage through the administration of thyroid hormone.
Thyroid function and anti-thyroid antibodies in MS patients screened for interferon treatment. A multicenter study.
Durelli L, Oggero A, Verdun E, Isoardo GL, Barbero P, Bergamasco B, Brossa PC, Ghigo E, Maccario M, Faggiano F; Betaferon
Safety Trial (BEST) Study Group.
J Neurol Sci. 2001 Dec 15;193(1):17-22.
"Interferon beta (IFNB) treatment for multiple sclerosis (MS) has been associated with thyroid disorders (TD), in particular in
patients with subclinical TD or anti-thyroid (AT) autoantibodies (autoAb) before starting treatment. TD and AT autoAb
frequency was reported increased in MS.
To determine whether MS patients have subclinical thyroid function abnormalities or anti-thyroid autoimmunity predisposing to
develop TD, we performed a prospective multicenter screening of thyroid function and autoimmunity in 152 relapsing-remitting
(RR) MS patients selected to receive IFNB treatment and in 437 healthy normothyroidal controls. Thyroid-related hormones and
anti-thyroid microsomal antigen (anti-TMA) autoAb were tested with sensitive immunoradiometric or chromatographic assays.
Cases were stratified for different progressively decreasing or increasing cutoff values of thyroid-stimulating hormone (TSH) (0.3,
0.2, 0.1, 3 and 5 mIU/l), and odds ratios (OR) with 95% confidence intervals (CI) calculated using logistic regression adjusted
for gender, age, and anti-TMA autoAb positivity.
The frequency of cases below or above the TSH cutoff values was not significantly different in MS patients and controls, and
the risk to have an abnormal TSH level was not significantly increased in MS patients (OR ranging 0.37-0.84; CI, 0.05-3.01),
even if anti-TMA autoAb positive (OR ranging 0.35-0.85; CI, 0.04-3.00). Frequencies of subclinical hypothyroidism and of
anti-TMA autoAb positivity were, however, trending higher in MS men (ranging 5-7%) than in controls (3%).
MS patients do not have an increased risk of subtle thyroid function abnormalities, subclinical TD, or anti-TMA autoAb
positivity that may predispose to develop thyroid dysfunction during IFNB treatment. The positive trend for subclinical
hypothyroidism and anti-TMA autoAb positivity, however, advises a longitudinal study of thyroid function and autoimmunity
during IFNB treatment to see whether patients with baseline subclinical thyroid dysfunction develop clinically significant
alteration during treatment.
Characterization of myelin basic protein thyroid hormone response element and its function in the context of native and
Farsetti A, Desvergne B, Hallenbeck P, Robbins J, Nikodem VM.
J Biol Chem. 1992 Aug 5;267(22):15784-8.
"In this report we have characterized further the myelin basic protein (MBP) gene thyroid hormone response element (TRE) by
functional and binding analysis. Mutation and deletion experiments revealed that this TRE, confined to the sequences -184 to
-167 of the MBP promoter, is able to function as a classical regulatory element in the context of the native and a heterologous
promoter. It is comprised of two regions, containing a motif that is highly conserved among other TREs: AGGACA, arranged as
an inverted palindrome. Any mutation within the footprinted region impaired receptor binding and function. Moreover, the
deletion of sequences outside of the receptor footprinted region (MBP-TRE-18) resulted in a higher triiodothyronine
responsiveness and a concomitant increase in receptor-dependent, hormone-independent repression. Results of transfection
assays showed that both receptors alpha and beta elicit indistinguishable triiodothyronine responses when the MBP-TRE
functions as a regulator of a heterologous promoter activity. However, a preferential beta receptor transactivation was observed
when the MBP-TRE was placed in the context of its native promoter."
Molecular basis of thyroid hormone regulation of myelin basic protein gene expression in rodent brain.
Farsetti A, Mitsuhashi T, Desvergne B, Robbins J, Nikodem VM.
J Biol Chem. 1991 Dec 5;266(34):23226-32. Erratum in: J Biol Chem 1992 Aug 25;267(24):17478.
Regulation of myelin basic protein (MBP) gene expression by thyroid hormone has been investigated in rodent brain.
Quantitation of the 4 major alternatively spliced transcripts by RNase protection assay showed that the individual mRNAs,
corresponding to MBP isoforms 21.5, 18.5, 17, and 14 kDa, were decreased from 2- to 17-fold at all ages studied (4-60 days) in
hypothyroid animals when compared to euthyroid, but the timing of onset of expression was not altered. MBP mRNA was also
reduced in young adult rats thyroidectomized at the age of 5-6 weeks and was restored to normal by thyroxine administration.
Nuclear run-off assays showed that the rate of MBP gene transcription is dependent on thyroid state. Co-transfection of MBP
(-256/+1)-chloramphenicol acetyltransferase chimeric gene with a plasmid expressing thyroid hormone receptor alpha, and in
the presence of 3,5,3'-triiodothyronine, into NIH3T3 or NG108-15, increased chloramphenicol acetyltransferase expression
4-fold. Using a footprinting technique and Spodoptera frugiperda 9 (Sf9) nuclear extract infected with baculovirus expressing
TR alpha, we have identified a single DNA-binding site (-186/-163) for the receptor. A part of this region contains the AGGACA
sequence found in thyroid hormone-responsive elements of other 3,5,3'-triiodothyronine-regulated genes. Our finding of a
specific hormone-receptor interaction with the MBP promoter region is the first direct demonstration of a thyroid
hormone-responsive element in a brain-specific gene.
The iodine-selenium connection: its possible roles in intelligence, cretinism, sudden infant death syndrome, breast cancer and
Med Hypotheses. 1993 Jan;40(1):61-5. Review.
Several diseases and disorders display spatial patterns that suggest the involvement of both selenium and iodine deficiencies,
or excesses, in their etiologies. It is suggested that many of these similarities in geographical distribution occur because both
elements influence thyroid hormone metabolism.
Disease family trees: the possible roles of iodine in goitre, cretinism, multiple sclerosis, amyotrophic lateral sclerosis,
Alzheimer's and Parkinson's diseases and cancers of the thyroid, nervous system and skin.
Med Hypotheses. 1987 Nov;24(3):249-63. Review.
Geographical distribution patterns of incidence and mortality for a wide variety of diseases display strong positive and negative
correlations when analyzed statistically. It is argued that these relationships do not occur by chance, but reflect the causal role
of surpluses and/or deficiencies of various bulk and trace elements. This concept is explored for one such "disease family tree",
that of iodine. Deficiencies of this essential trace element appear to be associated with many diseases, or birth defects,
including goitre, cretinism, multiple sclerosis, amyotrophic lateral sclerosis and cancer of the thyroid and nervous system.
Although the evidence is weaker, iodine deficiency may also be implicated in Alzheimer's and Parkinson's diseases. In contrast,
too much iodine may be linked to elevated mortality from cancer of the skin and melanoma. Rat studies indicate that iodine
deficiencies can cause reduced brain weight, limited myelin formation, retarded neuronal maturation, a lowering of the
production of various enzymes and slowing of the rates of protein and R.N.A. synthesis. Similar processes appear to occur in
many of the diseases identified above.
Association of MS with thyroid disorders.
Karni A, Abramsky O.
Neurology. 1999 Sep 11;53(4):883-5.
A controlled prospective study was conducted to determine whether thyroid disorders are present with increased frequency in
patients with MS. We found that thyroid disorders were at least three times more common in women with MS than in female
controls. This was accounted for mainly by the prevalence of hypothyroidism among the female MS patients. Because
hypothyroidism is usually due to Hashimoto's thyroiditis, its association with MS may support the hypothesis of autoimmune
pathogenesis for MS. Our findings might have therapeutic implications because interferon treatment can induce antithyroid
antibodies and thyroiditis.
Myelin basic protein immunoreactivity in the internal capsule of neonates from rats on a low iodine intake or on
Martinez-Galan JR, Pedraza P, Santacana M, Escobar del Rey F, Morreale de Escobar G, Ruiz-Marcos A.
Brain Res Dev Brain Res. 1997 Jul 18;101(1-2):249-56.
"Rats fed on low iodine diets (LIDs) result in a normal circulating level of triiodothyronine (T3), a low level of thyroxine (T4) and
an elevated thyroid-stimulating hormone (TSH). These changes are similar to those observed in habitants who live in
iodine-deficient areas and different from those observed when the hypothyroidism is produced by goitrogens. To study the
effects of LID or goitrogens on the myelin basic protein (MBP) immunoreactivity (MBP-ir) during the myelination of the internal
capsule, one group of experimental female rats was fed on an LID, and another group received a standard laboratory diet with
methylmercaptoimidazole (MMI) added in the drinking water. Animals fed on a standard laboratory diet and animals fed on an
LID supplemented with KI were used as controls. At P10, the MMI treatment has produced a more marked decrease in the
surface density of MBP-ir processes with respect to controls than that produced in the LID animals. This decrease was
correlated with the cerebral concentrations of triiodothyronine (T3) we found. During the postnatal development, a recovery in
the levels of the surface density with respect to controls was observed in both experimental groups. The recovery occurred by
P20 in the LID group and by P32 in the MMI rats.
Prevalence of autoimmune thyroiditis and non-immune thyroid disease in multiple sclerosis.
Niederwieser G, Buchinger W, Bonelli RM, Berghold A, Reisecker F, Koltringer P, Archelos JJ.
J Neurol. 2003 Jun;250(6):672-5.
"Since multiple sclerosis (MS) and autoimmune thyroiditis (AIT) are presumed to be of autoimmune origin the correlation of
these two diseases is of special interest. The aim of this study was to determine whether there are differences in the prevalence
of thyroid disease with special emphasis on AIT compared with MS and normal subjects and whether the presence of thyroid
disease correlates with disability, disease course, age, and disease duration. 353 consecutive patients with clinically definite
MS, without interferon-beta treatment and 308 patients with low back pain or headache were extensively examined for the
presence of non-immune or autoimmune thyroid disease. We found a significantly higher prevalence of AIT in male MS
patients (9.4 %) than in male controls (1.9 %; p = 0.03). The prevalence of AIT in female MS patients (8.7 %) did not differ from
female controls (9.2 %). Hypothyroidism, caused by AIT in almost all cases, showed a tendency to be more severe and more
often present in patients with MS. There was no association between relapsing-remitting and secondary progressive disease
course of MS and the prevalence of AIT. MS patients with AIT were significantly older but did not differ in disease duration and
expanded disability status scale (EDSS). Further studies are warranted, to see if there is a difference in sex-hormone levels
between MS patients with and without AIT and healthy controls. Longitudinal studies comparing MS patients with or without
AIT could show whether there is an influence of AIT on the disease course or progression.